Cargando…
Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug
BACKGROUND: Photodynamic therapy (PDT) is a light activated drug therapy that can be used to treat a number of cancers and precancers. It is particularly useful in its topical form in dermatology but improvement of efficacy is required to widen its application. METHODS: An ester between aminolaevuli...
Autores principales: | Curnow, Alison, Perry, Alexis, Wood, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456724/ https://www.ncbi.nlm.nih.gov/pubmed/30553949 http://dx.doi.org/10.1016/j.pdpdt.2018.12.005 |
Ejemplares similares
-
An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy
por: Anayo, Lizette, et al.
Publicado: (2018) -
Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy
por: Magnussen, Anette, et al.
Publicado: (2021) -
Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents.
por: Curnow, A., et al.
Publicado: (1998) -
The role of reperfusion injury in photodynamic therapy with 5-aminolaevulinic acid – a study on normal rat colon
por: Curnow, A, et al.
Publicado: (2002) -
The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells.
por: Berg, K., et al.
Publicado: (1996)